Dr Reddy's Laboratories Ltd, India's second largest drugmaker by sales, would issue bonus debentures worth 5.20 billion rupees ($116 million) to its shareholders, the company announced.
Davunetide significantly increases neuroprotective biomarker level in schizophrenia patients, Allon Therapeutics Inc studies showed.
Tesetaxel, an oral therapy against advanced gastric cancer, will soon undergo safety studies in humans.
Acetylcysteine can be useful in treating liver failure, results from studies conducted by Cumberland Pharmaceuticals Inc suggest.
SCV-07, an experimental drug to treat oral mucositis caused by chemotherapy, has been shown to delay the occurrence of the severe form of the disease.
Indian generic firm Indoco Remedies has entered into a supply arrangement with South Africa's Aspen on ophthalmic products for emerging markets.
Reolysin, an investigative drug to be used in combination with carboplatin and paclitaxel in patients with lung cancer, will soon undergo phase 2 studies to evaluate its efficacy.
Daiichi Sankyo Co has stated that the Japanese firm has no plans to delist Ranbaxy from Indian bourses denying reports.
Parenteral Biotech Ltd., a subsidiary of Parenteral Drugs (India), Ltd will launch Sinovac's seasonal influenza vaccine Anflu and H1N1 vaccine Panflu.1 in India.
AIKO-150, an experimental drug to treat to treat constipation associated with opoid use, has completed the second phase-I human clinical, Aiko Bio announced.